Abrocitinib treatment in adolescents and adults with moderate-to-severe atopic dermatitis: Early pruritus responses from phase 3 trials jade mono-1 and jade mono-2 This content is password protected. To view it please enter your password below: Password: {{#message}}{{{message}}}{{/message}}{{^message}}Your submission failed. The server responded with {{status_text}} (code {{status_code}}). Please contact the developer of this form processor to improve this message. Learn More{{/message}}{{#message}}{{{message}}}{{/message}}{{^message}}It appears your submission was successful. Even though the server responded OK, it is possible the submission was not processed. Please contact the developer of this form processor to improve this message. Learn More{{/message}}Submitting…